The largest database of trusted experimental protocols

110 protocols using phospho s6

1

Immunohistochemical and Western Blot Analysis of Biological Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues were fixed in 10% formalin overnight and embedded in paraffin. Immunohistochemical (IHC) and immunofluorescence (IF) staining was performed as previously described11 (link),14 (link). IHC slides were scanned with Pannoramic Digital Slide Scanner (3DHISTECH) and images were cropped from virtual slides in Pannoramic Viewer. IF slides were imaged with Nikon A1R Confocal Laser Microscope and quantified with ImageJ. Primary antibodies used include CK5 (Covance, PRB-160P), CK8 (Covance, MMS-162P), Ki67 (Fisher, RM-9106-S1), cleaved caspase 3 (Cell Signaling Technology, 9661), Gr-1 (BioLegend, 108401), phospho-S6 (Cell Signaling Technology, 4858). For Western blot analysis, cells or fresh tissues were lysed on ice using RIPA buffer (Boston BioProducts) supplemented with protease and phosphatase inhibitors (Roche). Western blot procedure was performed as previously described11 (link),14 (link). Primary antibodies used include phospho-Met (Cell Signaling Technology, 3077), phospho-VEGFR2 (Cell Signaling Technology, 3770), phospho-Erk1/2 (Cell Signaling Technology, 4370), phospho-Akt (Cell Signaling Technology, 4060), phospho-mTOR (Cell Signaling Technology, 5536), phospho-p70 S6K (Cell Signaling Technology, 9234), phospho-S6 (Cell Signaling Technology, 4856), and vinculin (Millipore, 05-386).
+ Open protocol
+ Expand
2

Western Blot Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.5% NP-40; 50 mM NaF with protease inhibitors) and incubated on ice for 30 min. Lysates were centrifuged at 20,817g at 4 °C for 10 min and supernatant was collected. Protein concentration was determined using the Bradford assay (Bio-Rad Laboratories, Hercules, CA). Equal amounts of protein samples were mixed with SDS Laemmli loading buffer, boiled and electrophoresed using NuPAGE Bis-Tris Gels (Life Technologies), then transferred onto PVDF membranes (Millipore). Blocking was performed for 45 min using TBST supplemented with 5% non-fat dry milk and blotting performed with primary antibodies at 4 °C for 16 h. The following antibodies were used: ADSL (Abcam #ab154182), GMPS (Cell Signaling #14602), PRPS1 (Abcam #ab154721), MYC (N-262, Santa Cruz #sc-764), total AKT (Cell Signaling #4691), phospho-AKT (S473, Cell Signaling #9271), total S6 (Cell Signaling #2317), phospho-S6 (235/236, Cell Signaling #4858), phospho-S6 (240/242, Cell Signaling #5364), total p70 S6K (Cell Signaling #2708), phospho-p70 S6K (Cell Signaling #9234) and α-tubulin (Sigma #T6074). All antibody validation information is available in the product’s manual. For western blotting, the dilution was 1:500 for MYC antibody and 1:1,000 for all other antibodies.
+ Open protocol
+ Expand
3

Immunohistochemical and Western Blot Analysis of Biological Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues were fixed in 10% formalin overnight and embedded in paraffin. Immunohistochemical (IHC) and immunofluorescence (IF) staining was performed as previously described11 (link),14 (link). IHC slides were scanned with Pannoramic Digital Slide Scanner (3DHISTECH) and images were cropped from virtual slides in Pannoramic Viewer. IF slides were imaged with Nikon A1R Confocal Laser Microscope and quantified with ImageJ. Primary antibodies used include CK5 (Covance, PRB-160P), CK8 (Covance, MMS-162P), Ki67 (Fisher, RM-9106-S1), cleaved caspase 3 (Cell Signaling Technology, 9661), Gr-1 (BioLegend, 108401), phospho-S6 (Cell Signaling Technology, 4858). For Western blot analysis, cells or fresh tissues were lysed on ice using RIPA buffer (Boston BioProducts) supplemented with protease and phosphatase inhibitors (Roche). Western blot procedure was performed as previously described11 (link),14 (link). Primary antibodies used include phospho-Met (Cell Signaling Technology, 3077), phospho-VEGFR2 (Cell Signaling Technology, 3770), phospho-Erk1/2 (Cell Signaling Technology, 4370), phospho-Akt (Cell Signaling Technology, 4060), phospho-mTOR (Cell Signaling Technology, 5536), phospho-p70 S6K (Cell Signaling Technology, 9234), phospho-S6 (Cell Signaling Technology, 4856), and vinculin (Millipore, 05-386).
+ Open protocol
+ Expand
4

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates were prepared in Laemmli sample buffer containing β-mercaptoethanol. Proteins were resolved by SDS-PAGE and transferred to PVDF. Membranes were blocked in 1% BSA and incubated in primary antibodies overnight at 4 °C. Proteins were detected using HRP secondary antibodies and chemiluminescence substrate (Pierce, Rockford, IL, USA) on a ChemiDoc Imaging System (Bio-Rad, Hercules, CA, USA). The following primary antibodies were used: BAP1 (#13271), Aurora-A (#3092), PLK1 (#4513), cyclin B1 (#4135), Wee1 (#4936), phospho-RB (#9308), S6 (#2217), PKM2 (#3198), GLUT1 (#12939), HK1 (#2024), HK2 (#2867), PKM2 (#3198), FASN (#3180), ACC (#3662), ACSL1 (#9189), ACLY (#4332), CPT1A (#12252), phospho-ACC (S79, #3661), phospho-mTOR (S2448, #2971), mTOR (#2983), phospho-ERK1/2 (#9101), ERK1/2 (#9102), phospho-S6 (S235/236, #4857), phospho-S6 (S240/244, #2215), and HSP90 (#4877) from Cell Signaling Technology; CPT1C (ab123794) from Abcam (Cambridge, UK); GLUT3 (sc-30107) and GNAQ (sc-393) from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA); SREBP1 (#557036) from BD Pharmingen and β-actin (#A2066) from Sigma-Aldrich.
+ Open protocol
+ Expand
5

Whole Cell Lysate Preparation and Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare whole cell lysates, cells or tissues were lysed in Buffer B as described previously [7 (link)]. For immunoprecipitations, 200 μg whole cell lysate was diluted in IP buffer and immunoprecipitated with 4G10 anti-phosphotyrosine agarose conjugate (05-777, Millipore) as described previously [9 (link)]. Whole cell lysates and immunoprecipitates were processed by WES to separate and visualize cellular proteins according to a standard instrument protocol. Primary antibodies used were: Ron β (#sc-374626, 1:25), GAPDH (#sc-25778, 1:300), PCNA (#sc-56, 1:25) from Santa Cruz Biotechnology; pan AKT (#4691, 1:25), phospho-AKT (#9271, 1:25), S6 (#2217, 1:25), phospho-S6 (#4856, 1:25), phospho-eIF4B (#3591, 1:25), phosphor-AKT1(# 9018, 1:25), phosphor-AKT2 (# 8599, 1:25), AKT1(# 2938, 1:25), AKT2 (# 3063, 1:25), phospho-S6K1 (#9234, 1:25), S6K1 (#2708, 1:25), cleaved PARP (#9541, 1:25), phospho-GSK3α/β (#9331, 1:25), GSK3α/β (#5676, 1:25), Met (#8198, 1:25), Ret (#14556, 1:25) and Axl (#8661, 1:25) from Cell Signaling Technology. Secondary antibodies were included in a Wes Master Kit (PS-MK14, ProteinSimple).
+ Open protocol
+ Expand
6

Western Blot Analysis of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Crushed tumors were lysed in ice-cold RIPA lysis buffer [50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM MgCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, protease and phosphatase inhibitor cocktail (Thermo Scientific)]. Equal amounts of total protein were separated by SDS-PAGE and probed as indicated. Signals were detected using either SuperSignal West Pico or Femto chemiluminescent substrates (Pierce Biotechnology). Antibodies for immunoblotting against EGFRL858R (#3197), phospho-EGFR-Y1068 (#2234), phospho-Erbb2-Y1248 (#2247), AKT (#2938), phospho-AKT (#4060), ERK1/2 (#9102), phospho-ERK (#4376), S6 (#2217), phospho-S6 (#5364), GAPDH (#2118) and the secondary anti-rabbit HRP antibody (#7074) were from Cell Signaling Technology (CST). Additional antibodies include: Erbb2 (Millipore, 06-562), and SPC (Abcam, #ab90716). All the antibodies were used at the dilutions suggested by manufacturer.
+ Open protocol
+ Expand
7

Immunoblotting analysis of cancer cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cancer cell lines were purchased from ATCC, Manassas, VA. Human Mammary Epithelial cells immortalized by telomerase expression (tert-HMEC) have been described previously [35 (link)]. Cells were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum. Cell extracts were prepared as described previously [36 (link)] and immunoblot analysis was carried out with the following antibodies: EGFR (#4267), phospho-EGFR[Y845] (#6963), PARP (#9532), phospho-Akt[T308] (#9275), Akt (#4691), phospho-Erk (#9101), HER2 (#2165), HER3 (#4754), phospho-HER2[Y877] (#2241), and phospho-S6 (#2211) from Cell Signaling Technology, Danvers, MA; Erk (sc-93), phospho-Tyrosine (sc-7020), and Actin (sc-1616) from Santa Cruz Biotechnology, Santa Cruz, CA; phospho-Tyrosine (4G-10, 05–321) from Millipore, Temecula, CA; E-cadherin (610182) from BD Transduction Laboratories, San Jose, CA.
+ Open protocol
+ Expand
8

SARS-CoV-2 N Protein Expression and Antibody Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SARS-CoV-2 N gene was PCR-amplified from cDNA derived from the isolate SARS-CoV-2/human/USA/CA-CZB017/2020 (GenBank MT385497.1), nucleotides 28254 to 29513, and cloned into pCS2MT in frame with five N-terminal myc epitope tags (https://www.addgene.org/153201/). Priming site mutations were generated by site-directed mutagenesis to modify serine-188 and serine-206 to alanine based on prior observations with SARS-CoV-1 (8 (link)). Antibodies to the SARS-CoV-2 N protein were purchased from Invitrogen (#PA1-41386). Antibodies from Cell Signaling included phospho-Glycogen Synthase (#3891), phospho-S6 (#4858), β-catenin (#9562), phospho-β-catenin (#9561), GAPDH (#2118), PKCα (#2056), PKCδ (#2058), PKCε (#2683), Myc-tag (#2276), and phospho (Ser) substrate (#2261). Other antibodies included antibodies to GSK-3 (Calbiochem #368662), Tau (T14/46 antibodies provided by Virginia Lee, University of Pennsylvania, Philadelphia, PA), and β-actin (Sigma #A5441). Monoclonal anti–SARS-CoV S Protein (similar to 240C) was obtained through BEI Resources, National Institute of Allergy and Infectious Diseases, NIH (NR-616).
+ Open protocol
+ Expand
9

Immunoblotting and Antibody Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was performed as described previously (Jacobs et al., 2008). Primary antibodies were followed by mouse- or rabbit-conjugated horseradish peroxidase (HRP). HRP-conjugated antibodies (anti-mouse or anti-rabbit IgG HRP conjugate, Promega) were detected by enhanced chemiluminescence detection (Thermofisher). This included the following antibodies: ACC (3662, Cell Signaling), phospho-ACC (3661, Cell Signaling), pan-AMPKα (2532, Cell Signaling), phospho-AMPKα (2535, Cell Signaling), 4EBP1 (9644, Cell Signaling), phospho-4EBP1 (2855, Cell Signaling), c-myc (9402, Cell Signaling), phospho-mTOR (5536, Cell Signaling), Activated Notch (ab8925, Abcam), RAPTOR (2280, Cell Signaling), phospho-RAPTOR (2083, Cell Signaling), S6 (2217, Cell Signaling), phospho-p70 S6K (9204, Cell Signaling), p70 S6K (2708, Cell Signaling), phosphor-TSC2 (5584, Cell Signaling), TSC2 (3612, Cell Signaling). Alternatively, primary antibodies were followed by fluorescently labeled anti-mouse or rabbit antibodies (LiCor) and imaged using the Odyssey infrared imaging system (LiCor). This included the following antibodies: Glut1 (ab652, Abcam), hexokinase 2 (2867, Cell Signaling), hexokinase 1 (ab104835, Abcam), cytochrome C (556433, BD Biosciences), β-actin (A5441, Sigma), phospho-S6 (4858, Cell Signaling). Western blots were quantified using ImageJ software.
+ Open protocol
+ Expand
10

Western Blot Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated for 24 h at the indicated concentrations with the respective drugs. Total protein lysates were prepared, separated, and transferred onto a polyvinylidene difluoride membrane for Western blotting as described previously [75 (link)]. Following antibodies were used: Santa Cruz Biotechnology Inc (CA, USA): PDE4D (#sc-25100), 1:200; Rap1 (#sc-65) 1:1000; deprenylated Rap1 (C-17; Rap1A, #sc-65) 1:1000. Cell signaling Technology (MA, USA): phospho-PKA substrate (#9624), 1:1000; Creb (#9104), 1:1000; phospho-Creb (Ser133; #9198), 1:1000; Epac1 (#4155), 1:1000; Integrin α5 (#4705), 1:1000; Integrin αv (#4711), 1:1000; Integrin β1 (#9699), 1:1000; Integrin β5 (#3629), 1:1000; phospho-Erk (Thr202/Tyr204; #9101), 1:1000; Erk (#9102), 1:1000; phospho-S6 (Ser240/244; #2215), 1:1000; S6 (#2317), 1:1000; phospho-Src (Tyr416; #2101), 1:1000; Src (#2109), 1:1000; Rac (#2465), 1:1000; RhoA (67B9; #2117), 1:1000, and Vinculin (E1E9V, #13901). Sigma-Aldrich: β-actin (AC-15; #A1978), 1:1000. Secondary, horseradish peroxidase-labeled antibodies from Cell Signaling Technologies were used in working dilutions of 1:10 000.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!